效价
接种疫苗
抗体
医学
抗体效价
免疫
免疫学
队列
中和抗体
免疫分析
免疫球蛋白G
内科学
免疫系统
作者
Yurie Kobashi,Yoshitake Takebayashi,Makoto Yoshida,Takashi Kawamura,Yuzo Shimazu,Yudai Kaneko,Yoshitaka Nishikawa,Aya Nakayama,Morihito Takita,Tianchen Zhao,Chika Yamamoto,Naomi Ito,Masaharu Tsubokura
出处
期刊:Vaccines
[MDPI AG]
日期:2022-11-25
卷期号:10 (12): 2007-2007
被引量:5
标识
DOI:10.3390/vaccines10122007
摘要
Measuring long-term antibody titer kinetics and subsequent coronavirus disease 2019 (COVID-19) vaccinations are crucial for identifying vulnerable populations. Our aim was to determine the association between long-term antibody kinetics, including peak titers and factors, up to seven months post-second vaccination. A three-time antibody survey was conducted in 2021 among healthcare workers in Japan to investigate the changes in humoral immunity using chemiluminescence immunoassay. The study involved 205 participants who had received the second vaccine dose, completed the three-time survey, and were not infected with SARS-CoV-2. A latent growth curve model was used to identify factors affecting the peak titer and decreasing the antibody slope. Of the eligible participants, the mean titers of immunoglobulin G (IgG) against the spike (S) protein and the neutralizing activity 7 months after the second vaccination decreased to 154.3 (8.8% of the peak titer) and 62.1 AU/mL (9.5% of the peak titer), respectively. The IgG growth model showed that age significantly affected peak titers (p < 0.001); however, a significant difference was not found for the decreasing slope. Ultimately, aging adults had significantly low peak antibody titers; however, age was unrelated to the slope of log-transformed IgG against the S protein.
科研通智能强力驱动
Strongly Powered by AbleSci AI